CCTN September Webinar: Prehospital Treatment for OUD |
|

The NIDA Center for the Clinical Trials Network (CCTN) is hosting a virtual workshop titled "Prehospital Treatment for Opioid Use Disorde" on Tuesday, September 6, 2022, from 11am-5pm ET.
This event will bring together stakeholders, experts, and federal staff to present recent research and innovative EMS or paramedic administered approaches for opioid use disorder and overdose and to identify research needed to evaluate prehospital approaches for opioid use disorder. It will highlight promising research, describe innovative programs in the United States, and identify research priorities to inform research planning.
An email will be sent to all registered attendees a few days before the meeting with the final agenda and list of speakers and panel participants.
Individuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event, should contact Sean Randol at (240) 863-0507 or srandol@leedmci.com or through the Federal Relay (1-800-877-8339). Requests should be made at least five business days in advance of the event.
Register for this event here.
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
Reminder: New Mailing Address for the CCTN
The CCTN Address has changed! Please contact them at:
Center for the Clinical Trials Network, NIDA, NIH
3 White Flint North, MSC 6022
16701 Industrial Drive
Gaithersburg, MD 20877
|
CTN Trial Progress
Randomizations for Active Studies as of the July 13 Trial Progress Report.
CTN-0060-A-1 - Enrolled 811
CTN-0080 - Enrolled 95
CTN-0097 - Enrolled 413
CTN-0098 - Enrolled 55
CTN-0099 - Enrolled 1016
CTN-0099-A-1 - Enrolled 87
CTN-0100
Discontinuation - Enrolled 58
Retention - Enrolled 392
CTN-0101 - Enrolled 158
CTN-0107 - Enrolled 57
CTN-0108 - Enrolled 32
|
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
CTN Youth SIG Webinar: Promoting Health in Hispanic Families: 20 Years of Research, Lessons Learned, and Opportunities
July 22, 2022 | 11:00am-12:00pm ET
Join Zoom meeting
Presenter: Guillermo (Willy) Prado, PhD
Vice Provost, Faculty Affairs
Dean, Graduate School
Professor of Nursing and Health Studies, Public Health Sciences, and Psychology
University of Miami
This presentation will provide an overview of a program of research focused on promoting health and reducing health disparities among Hispanic/Latinx youth and their families. The presentation will mainly focus on the Familias Unidas preventive intervention and include the theoretical framework of the intervention, the mechanisms of action, and the findings from efficacy, effectiveness, and effectiveness-implementation studies. Lessons learned and opportunities for future research will also be discussed.
About the presenter
Dr. Willy Prado’s research lab focuses on developing and evaluating culturally specific family-based preventive interventions in Latinx youth and on translating these interventions into clinical and community practice. Prado, an elected member of the National Academy of Medicine, is also the Director of the Investigator Development/Mentoring and Training Core of the Center for Latino Health Research Opportunities.
Full Zoom details
Join Meeting
Zoom Meeting ID: 910 5122 3250
Passcode: 609671
Phone one-tap: US: +13017158592,,91051223250#,,,,*609671# or +13126266799,,91051223250#,,,,*609671
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
New from NIDA
Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity
NIDA, NIMH, and NNINDS are please to share a new and groundbreaking funding opportunity, the "NIDA, NIMH, and NINDS Research Opportunities for New and ‘At-Risk’ Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)."
his program is intended to support New and At-Risk Investigators from diverse backgrounds, including those from groups underrepresented in the health-related sciences proposing research within the mission of the participating NIH Institutes.
An investigator is considered a New Investigator (NI) if he/she has not competed successfully for substantial, NIH independent funding from NIH.
An investigator is considered an At-Risk Investigator if they have had prior support as a Principal Investigator on a substantial independent research award and, unless successful in securing a substantial research grant award in the current fiscal year, will have no substantial research grant funding in the following fiscal year.
NIDA intends to commit up to $5 million per fiscal year for this program.
See the FOA, PAR-22-181, to learn more about eligibility, the required Institutional Eligibility Letter, and other important aspects of this new opportunity.
Contact Dr. Albert Avila (aavila@nida.nih.gov) if you have any questions.
|
NIDA News Items
Percentage of Overdose Deaths Involving Methadone Declined Between January 2019 and August 2021 (NIDA News Release)
National data indicate that COVID-era expansion of methadone treatment for opioid use disorder was not associated with harms, adding evidence to support continuing take-home treatment protocols for medications for OUD.
"Treatment is an essential tool to stop the addiction and overdose crises, but it is vastly underused," said NIDA Director and senior author, Nora Volkow, M.D. "This evidence adds significant weight to the argument that effective treatment for substance use disorders should be offered in an accessible and practical way that works for people who need it."
Read the news release here.
Time to Start Talking About Pre-Addiction
(Nora's Blog)
By the time someone reaches out for addiction care, they may have already suffered numerous painful losses in their lives. Frequently, when a person asks for help early on, society -- friends and family, coworkers, health care systems -- doesn't recognize it as a serious issue and may ignore or deny it.
NIDA Director Nora Volkow, Tom McLellan of the Treatment Research Institute, and NIAAA Director George Koob recently wrote a commentary piece published in JAMA Psychiatry that talks about moving toward a plan for better detection and support of those in early stages of substance use disorder that, if untreated, may lead them to develop a severe health condition: addiction.
Read Nora's blog post and the commentary piece here. |
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
New in the CTN Dissemination Library
Did you know that you can get free full-text for over 600 CTN-related journal articles in the CTN Dissemination Library? For all the others, if you can’t access it yourself, just click “Email CTN Library (free)” under “How to Get the Item” and the CTN Dissemination Librarian can send you a PDF!
Models for implementing emergency department-initiated buprenorphine with referral for ongoing medication treatment at emergency department discharge in diverse academic centers. Whiteside LK, et al. Annals of Emergency Medicine 2022 (in press). CTN-0069
Interested in emergency department-initiated buprenorphine?
Be sure to check out the recording of last month's CTN Western State Node and Northwest and Pacific Southwest ATTC's webinar from Gail D'Onofrio: Emergency Department-Initiated Buprenorphine for Opioid Use Disorder, presented on June 30, 2022. Download slides | Watch recording
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
|